# A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee

> **NCT00837291** · PHASE2 · WITHDRAWN · sponsor: **Can-Fite BioPharma**

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** CF101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00837291
- **Lead sponsor:** Can-Fite BioPharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-11
- **Primary completion:** 2018-12
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The company has decided not to conduct the study
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837291, "A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00837291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*